List view / Grid view

Protein

 

webinar

SH2 domains as a target class in cancer and inflammation

25 July 2023 | By Eurofins Discovery

New SH2 domain binding assays developed by Eurofins Discovery have been launched to support drug discovery initiatives in the protein-protein interaction space and in targeted protein degradation. We present small molecule case study data for important targets within this target class including STAT Transcription factors and Kinases.